GlassScriptPhysician profile
Bhavananda T Reddy
NPI 1326130758
$15,853.91
in general payments reported to CMS, 2019-2025
21 companies · $279 in 2025
The $279 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,708 · 2020: $986 · 2021: $646 · 2022: $2,435 · 2023: $1,574 · 2024: $3,226 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,561 · Travel and Lodging: $2,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,560.72 |
| Travel and Lodging | $2,518.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,798.22 | 2019-2023 | Watchman Access System, Synergy |
| Medtronic, INC. | $3,049.65 | 2022-2024 | Advisa Dr Mri Surescan, Adapta, Azure Xt Dr Mri Surescan |
| Inari Medical, INC. | $1,841.99 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $1,393.17 | 2019-2021 | |
| Philips North America LLC | $1,338.81 | 2019-2025 | (Bh4) Igt Devices Undivided, IV Other |
| Shockwave Medical, INC | $1,052.72 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| W. L. Gore & Associates, INC. | $907.55 | 2019 | |
| Abiomed | $265.77 | 2023 | Impella |
| Novartis Pharmaceuticals Corporation | $249.99 | 2022-2025 | |
| Kestra Medical Technology Services, INC. | $210.55 | 2023-2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $204.71 | 2023 | Optimizer |
| Amgen INC. | $111.76 | 2023-2025 | Repatha, Repatha, Tezspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.77 | 2022-2025 | Lifevest |
| Medtronic Vascular, INC. | $97.84 | 2019-2020 | |
| Novo Nordisk INC | $70.98 | 2025 | Wegovy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $62.72 | 2023 | Diamondback Coronary |
| Bard Peripheral Vascular, INC. | $31.91 | 2020-2025 | Rotarexs 6 F X 135 Cm |
| Kiniksa Pharmaceuticals, LTD. | $20.77 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $17.14 | 2019 | |
| Cook Medical LLC | $14.95 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhavananda Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.